Trial Profile
The effect of lifestyle-adjustments prior to medical treatment on the effect of medical treatment in reflux patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2008
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 06 May 2008 Actual start date changed from Feb 2006 to Jun 2004 as reported by Clinicaltrials.gov.
- 06 May 2008 Status change from in progress to completed, according to clinicaltrials.gov.
- 07 Sep 2007 New trial record.